“…Of the 389 SNPs (Adeyemo et al, 2009;Cho et al, 2009;Ehret et al, 2016;International Consortium for Blood Pressure Genome-Wide Association Studies et al, 2011;Evangelou et al, 2018;Fox et al, 2011;Franceschini et al, 2013;Ganesh et al, 2014Ganesh et al, , 2013Ho et al, 2011;Hoffmann et al, 2017;Johnson, Newton-Cheh, et al, 2011;Johnson, Gaunt, et al, 2011;Kato et al, 2015Kato et al, , 2011Kidambi et al, 2012;Levy et al, 2009;Li et al, 2017;Liang et al, 2017;Liu et al, 2016;Newton-Cheh, Johnson, et al, 2009;Newton-Cheh, Larson, et al, 2009;Parmar et al, 2016;Simino et al, 2014;Surendran et al, 2016;Takeuchi et al, 2010;Tragante et al, 2014;Wain et al, 2017Wain et al, , 2011Warren et al, 2017) identified for replication, 330 (85%) SNPs were included in the replication analysis. Fifty-nine SNPs that were either rare (<0.01) or poorly imputed (INFO score <0.3) in the EMaBS sample were not included in the replication analysis.…”